top of page


Cannabinoid-associated cell death mechanisms in tumor models (Review)

Calvaruso, Giuseppe, et al.

International Journal of Oncology. 2012 May 14, 41(2): 407-413 (Full)

Potentiation of Cannabinoid-Induced Cytotoxicity in Mantle Cell Lymphoma through Modulation of Ceramide Metabolism

Gustafsson, Kristin, et al.

Molecular Cancer Research. 2009 Jul 7, 1086 (Full online article).

Expression of cannabinoid receptors type 1 and type 2 in non-Hodgkin lymphoma: Growth inhibition by receptor activation

Gustafsson, Kristin, et al.

International Journal of Cancer. 2008 Sep 1, 123(5): 1025-1033 (Full).

The expression of the Peripheral Cannabinoid receptor on cells of the immune system and Non-Hodgkin’s lymphomas

Rayman, Nazik, et al.

Leukemia & Lymphoma. 2007, 48(7): 1389-1399 (abstract).

Cannabinoid Receptor-Mediated Apoptosis Induced by R(+)-Methanandamide and Win55,212-2 Is Associated with Ceramide Accumulation and p38 Activation in Mantle Cell Lymphoma

Gustafsson, Kristin, et al.

Molecular Pharmacology. 2006 Nov, 70(5): 1612-1620 (Full).

Cannabinoid receptor ligands mediate growth inhibition and cell death in mantle cell lymphoma

Flygare, Jenny, et al.

FEBS Letters. 2005 Dec 19, 579(30): 6885-6889 (Full).

Distinct Expression Profiles of the Peripheral Cannabinoid Receptor in Lymphoid Tissues Depending on Receptor Activation Status

Rayman, Nazik, et al.

The Journal of Immunology. 2004 Feb 15, 172(4): 2111-2117 (Full).

High level of cannabinoid receptor 1, absence of regulator of G protein signalling 13 and differential expression of Cyclin D1 in mantle cell lymphoma

Islam, T.C., et al.

Leukemia. 2003, 17: 1880-1890 (Full).

Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease

McKallip, Robert J, et al.

Blood. 2002 Jul 15, 100(2): 627-634 (Full).

Lymphoma: About Us
bottom of page